eCite Digital Repository

Incretin-based therapies


Bereznicki, L, Incretin-based therapies, Australian Pharmacist, 29, (6) pp. 508-513. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

Restricted - Request a copy

Copyright Statement

Copyright 2010 Pharmaceutical Society of Australia

Official URL:


The number of Australians with type 2 diabetes mellitus (T2DM) has tripled since 1981 and continues to increase. It is projected that 1.6 million Australians will have type 2 diabetes by 2030. Because T2DM frequently co-exists with excess weight, hypertension and dyslipidaemia, health professionals involved in the management of diabetes should focus on blood pressure management, cholesterol lowering and consider the use of lowdose aspirin for primary prevention (although this is now contentious) as means of reducing cardiovascular risk, in addition to targeting glycaemic control

Item Details

Item Type:Professional, Non Refereed Article
Keywords:Incretin based therapies, oral inhibitors, receptor agonists, clinical trials, diabetes
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Pharmacology and pharmaceutical sciences not elsewhere classified
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Bereznicki, L (Professor Luke Bereznicki)
ID Code:64292
Year Published:2010
Deposited By:Pharmacy
Deposited On:2010-07-14
Last Modified:2011-06-10
Downloads:1 View Download Statistics

Repository Staff Only: item control page